Concepedia

Publication | Closed Access

Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

DOI

778

Citations

46

References

2003

Year

C. Kent Osborne, V J Bardou, Torsten Hopp, Gary C. Chamness, Susan G. Hilsenbeck, Suzanne A.W. Fuqua, Jiemin Wong, D. Craig Allred, Gary M. Clark, R. Schiff
JNCI Journal of the National Cancer Institute

Abstract

The antitumor activity of tamoxifen in patients with breast cancer may be determined, in part, by tumor levels of AIB1 and HER-2. Thus, AIB1 may be an important diagnostic and therapeutic target.

References

YearCitations

Page 1